ALB and neoplasm: The compound with the best tumor-to-kidney ratio exhibited a tumor uptake of ~24 %IA/g and a kidney uptake of ~63 %IA/g 4 h after injection, whereas the reference compound without the albumin binder had a tumor uptake of ~9 %IA/g and kidney uptake of ~161 %IA/g [130].